TY - JOUR T1 - Changes in lipids and inflammation in adults with super-refractory status epilepticus on a ketogenic diet JF - medRxiv DO - 10.1101/2021.02.23.21252291 SP - 2021.02.23.21252291 AU - Alex M Dickens AU - Tory Johnson AU - Santosh Lamichhane AU - Jacqueline Lovett AU - Anupama Kumar AU - Carlos Pardo AU - Erie Gonzales Gutierrez AU - Bareng Nonyane AU - Ximin Li AU - Norman Haughey AU - Mackenzie C. Cervenka Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/24/2021.02.23.21252291.abstract N2 - Objective To test the hypothesis that increased ketone body production with a ketogenic diet (KD) will correlate with reductions in pro-inflammatory cytokines, lipid subspecies, and improved clinical outcomes in adults treated with an adjunctive ketogenic diet for super-refractory status epilepticus (SRSE).Methods Adults (18 years or older) were treated with a 4:1 (fat:carbohydrate and protein) ratio enteral KD as adjunctive therapy to pharmacologic seizure suppression for SRSE. Blood and urine samples and clinical measurements were collected at baseline (n=10), after 1 week (n=8), and after 2 weeks of KD (n=5). Urine acetoacetate, serum β-hydroxybutyrate, lipidomics, pro-inflammatory cytokines (IL-1β, IL-6), chemokines (CCL3, CCL4, CXCL13), and clinical measurements were obtained at these 3 time points. Univariate and multivariate data analyses were performed to determine the correlation between ketone body production and circulating lipids, inflammatory biomarkers, and clinical outcome.Results Changes in lipids included an increase in ceramides, mono-hexosyl ceramide, sphingomyelin, phosphocholine, and phosphoserines, and there was a significant reduction in IL-6 and CXCL13 seen at 1 and 2 weeks of KD. Higher blood β-hydroxybutyrate levels at baseline correlated with better clinical outcome however, ketone body production did not correlate with other variables during treatment. Higher pro-inflammatory chemokine CCL3 levels following treatment correlated with greater length of intensive care unit stay, higher modified Rankin Scale score (worse neurologic disability) at discharge and 6-month follow up.Conclusions Adults receiving an adjunctive enteral ketogenic diet for super-refractory status epilepticus have alterations in select pro-inflammatory cytokines and lipid species that may predict response to treatment.Competing Interest Statement Alex Dickens, DPhil Disclosure: Dr Dickens has worked part time for Orion Pharma (Finland). This study has nothing to do with his work at this company. Tory Johnson, PhD Disclosure: Dr. Johnson has nothing relevant to disclose. Mackenzie C. Cervenka, MD Disclosure: Dr. Cervenka receives or has received grants from Nutricia, Vitaflo, BrightFocus Foundation, and Army Research Laboratory. Honoraria from American Epilepsy Society, The Neurology Center, Epigenix, LivaNova, and Nutricia. Royalties from Demos/Springer. Consulting for Nutricia, Sage Therapeutics.Funding StatementStudy Funding: This study was funded by the Johns Hopkins Center for Status Epilepticus and NeuroinflammationAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Informed consent was obtained from a legally authorized representative and the Johns Hopkins Medicine Institutional Review Board approved the study (IRB # NA_00073063 and NA_00003551). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is avlible upon request ER -